The ferulic and gallic acid related compounds from natural origin were studied against xanthine oxidase and cyclooxygenase-2 along with their anti-inflammatory activity. The compounds gallic acid, ferulic acid, caffeic acid and p-coumaric acid revealed promising anti-inflammatory activity (30–40% TNF-α and 60–75% IL-6 inhibitory activity at 10 μM). Bioavailability of compounds were checked by in vitro cytotoxicity using CCK-8 cell lines and confirmed to be nontoxic, but found toxic at higher concentration (50 μM). Gallic, ferulic, caffeic acid was demonstrated potential dual inhibition toward xanthine oxidase and cyclooxygenase-2 as calculated by IC50: 68, 70.2, and 65 (μ/ml (xanthine oxidase) and 68.5, 65.2, and 62.5 μg/ml (cyclooxygenase-2), respectively. The structure activity relationship and in silico drug relevant properties (HBD, HBA, PSA, c LogP, ionization potential, molecular weight, EHOMO and ELUMO) further confirmed that the compounds were potential candidates for future drug discovery study, which was expected for further rational drug design against xanthine oxidase and cyclooxygenase.
Aggarwal, B.B., Prasad, S., Reuter, S., Kannappan, R., Yadev, V.R., Park, B., Sung, B., 2011. Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr. Drug Targets 12, 1595–1653.
Bandgar, B.P., Gawande, S.S., Bodade, R.G., Gawande, N.M., Khobragade, C.N., 2009. Synthesis and biological evaluation of a novel series of pyrazole chalcones as an anti-inflammatory, antioxidant and antimicrobial agents. Bioorg. Med. Chem. 17, 8168–8173.
Bandgar, B.P., Gawande, S.S., 2010. Synthesis and biological screening of a combinatorial library of β-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents. Bioorg. Med. Chem. 18, 2060–2065.
Bardin, T., 2004. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 71, 481–485.
Blobaum, A.L., Marnett, L.J., 2007. Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem. 50, 1425–1441.
Choi, H.K., Curhan, G., 2005. Gout: epidemiology and lifestyle choices. Curr. Opin. Rheumatol. 17, 341–345.
Dineer, H.E., Dineer, A.P., LeVinson, D.J., 2002. Asymptomatic hyperuricemia: to treat or not to treat. Cleve Clin. J. Med. 69, 594–600.
Ellerin, T., Rubin, R.H., Weinblatt, M.E., 2003. Infections and anti-tumor necrosis factor α therapy. Arthritis Rheumatol. 48, 3013–3022.
Hoorn, D.E.C.V., Nijiveldt, R.J., Leeuwen, P.A.M.V., Hofman, Z., M’Rabet, L., Bont, D.B.A.D., Norren, K.V., 2002. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur. J. Pharmacol. 451, 111–118.
Kuek, A., Hazleman, B.L., Östör, A.J.K., 2007. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad. Med. J. 83, 251–260.
Li, Y., Frenz, C.M., Li, Z., Chen, M., Wang, Y., Li, F., Luo, C., Sun, J., Bohlin, L., Li, Z., Yang, H., Wang, C., 2013. Virtual and in vitro bioassay screening of phytochem-ical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment. Chem. Biol. Drug Des. 81, 537–544.
Mandell, B.F., 2002. Hyperuricemia and gout: a reign of complacency. Cleve Clin. J. Med. 69, 583–592.
Martinon, F., Glimcher, L.H., 2006. Gout: new insights into an old disease. J. Clin. Invest. 116, 2073–2075.
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., Tschopp, J., 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241.
Maxiaad, A., Sannaad, C., Frauad, M.A., Pirasbd, A., Karchulicd, M.S., Kasture, V., 2011. Anti-inflammatory activity of Pistacia lentiscus essential oil: involvement of IL-6 and TNF-α. Nat. Prod. Commun. 6, 1543–1544.
Mease, P.J., 2002. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann. Rheum. Dis. 61, 298–304.
Mohapatra, S., Kabiraj, P., Agarwal, T., Asthana, S., Annamalai, N., Arsad, H., Siddiqui, M.H., Khursheed, A., 2015. Targeting jatropha derived phytochemicals to inhibit the xanthine oxidase & cyclooxygenase-2: in silico analysis towards gout treatment. Int. J. Pharm. Pharm. Sci. 7, 360–363.
Nile, S.H., Kumar, B., Park, S.W., 2013. In vitro evaluation of selected benzimidazole derivatives as an antioxidant and xanthine oxidase inhibitors. Chem. Biol. Drug. Des. 82, 290–295.
Nile, S.H., Park, S.W., 2014a. Antioxidant α-glucosidase and xanthine oxidase inhibitory activity of bioactive compounds from maize (Zea mays L.). Chem. Biol. Drug. Des. 83, 119–125.
Nile, S.H., Park, S.W., 2014b. Edible berries: bioactive components and their effect on human health. Nutrition 30, 134–144.
Nile, S.H., Park, S.W., 2014c. HPTLC analysis, antioxidant and antigout activity of Indian plants. Iran. J. Pharm. Res. 12, 531–539.
Nile, S.H., Park, S.W., 2014d. HPTLC analysis, antioxidant, anti-inflammatory and antiproliferative activities of Arisaema tortuosum tuber extract. Pharm. Biol. 52, 221–227.
Nile, S.H., Park, S.W., 2013. Total phenolics, antioxidant and xanthine oxidase inhibitory activity of three colored onions (Allium cepa L.). Front. Life Sci. 7, 224–228.
Nile, S.H., Khobragade, C.N., 2011. In vitro anti-inflammatory and xanthine oxidase inhibitory activity of Tephrosia purpurea shoot extract. Nat. Prod. Commun. 6, 1437–1440.
Nuki, G., Simkin, P.A., 2006. A concise history of gout and hyperuricemia and their treatment. Arthritis Res. Ther. 8, 1–6.
Pouliot, M., James, M.J., McColl, S.R., Naccache, P.H., Cleland, L.G., 1998. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 91, 1769–1776.
Proestos, C., Boziaris, I.S., Nychas, J.E., 2005. Analysis of flavonoids and phenolic acids in Greek aromatic plants: investigation of their antioxidant capacity and antimicrobial activity. Food Chem. 93, 1998–2004.
Raso, G.M., Meli, R., DiCarlo, G., Pacilio, M., DiCarlo, R., 2001. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A. Life Sci. 68, 921–931.
Ricciotti, E., FitzGerald, G.A., 2011. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986–1000.
Shen, Y.C., Chen, S.L., Zhuang, S.R., Wang, C.K., 2008. Contribution of tomato phenolics to suppression of COX-2 expression in KB cells. J. Food Sci. 73, C1–C10.
This study was supported by KU-Research professor program-2015, Konkuk University, Seoul, South Korea.
The authors declare no conflicts of interest.
About this article
Cite this article
Nile, S.H., Ko, E.Y., Kim, D.H. et al. Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity. Rev. Bras. Farmacogn. 26, 50–55 (2016). https://doi.org/10.1016/j.bjp.2015.08.013
- Ferulic acid
- Gallic acid
- Xanthine oxidase